Supporting this hypothesis is data showing overexpression of B7-1 in PD-L1-expressing melanoma tumor cells prevented PD-L1 from binding to PD-1 and reduced the ability of these tumor cells to suppress T-cell activation [19,20,45]. The gene discussed is CD274; the disease is neoplasm.